Elsie Ilori

Datos Biográficos

ID7755992
NOMBREElsie Ilori
NOMBRESElsie
APELLIDOIlori
FIRMAILORI E
AFILIACIONESNigeria Centre for Disease Control
ORCID0000-0002-1731-2604
VERIFICADOSí
TOTAL DE OBRAS11
TOTAL DE CITAS0
TOTAL COMO AUTOR11
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2020
AÑO MÁS RECIENTE DE PUBLICACIÓN2024
ÍNDICE H0

  • Knowledge, risk perception and uptake of Covid-19 vaccination among internally displaced persons in complex humanitarian emergency setting, Northeast Nigeria

    Open AccessSaheed Gidado, Melton Musa et al.ARTICLEBMC Public Health2024

    This study revealed gaps in COVID-19 knowledge, risk perception, and vaccination uptake but demonstrated a significant relationship between risk perception and COVID-19 preventive practices. Health education and risk communication should be intensified to improve knowledge, elicit stronger risk perception, and enhance COVID-19 preventive practices

  • Benefits and challenges of consolidating public health functions into a National Public Health Institute

    Open AccessCaroline R Carnevale, Mahlet A Woldetsadik et al.ARTICLEHealth Policy and Planning2023

    National Public Health Institutes (NPHIs) around the world vary in composition. Consolidated organizational models can bring together critical functions such as disease surveillance, emergency preparedness and response, public health research, workforce development and laboratory diagnosis within a single focal point. This can lead to enhanced coordination and management of resources and enable more efficient and effective public health operation…

  • Adapting public health response through lessons learnt

    Open AccessFatima Saleh, Biliamin O Popoola et al.ARTICLEBMJ Global Health2022

    Response to public health emergencies requires continued adaptation and innovation. The Nigeria Centre for Disease Control (NCDC) is the country’s public health institute with the mandate to protect the health of Nigerians. Achieving such mandate in resource-limited settings with divergent demographic characteristics of the citizens, necessitates the readiness to learn from experience and to develop policies and activities in line with lessons le…

  • Seroprevalence of Sars-CoV-2 in four states of Nigeria in October 2020

    Open AccessRosemary Audu, Kristen A Stafford et al.ARTICLEPLOS Global Public Health2022

    The observed epidemiology of SARS-CoV-2 in sub-Saharan Africa has varied greatly from that in Europe and the United States, with much lower reported incidence. Population-based studies are needed to estimate true cumulative incidence of SARS-CoV-2 to inform public health interventions. This study estimated SARS-CoV-2 seroprevalence in four selected states in Nigeria in October 2020. We implemented a two-stage cluster sample household survey in fo…

  • Covid-19 mortality rate and its associated factors during the first and second waves in Nigeria

    Open AccessKelly Elimian, Anwar Musah et al.ARTICLEPLOS Global Public Health2022

    COVID-19 mortality rate has not been formally assessed in Nigeria. Thus, we aimed to address this gap and identify associated mortality risk factors during the first and second waves in Nigeria. This was a retrospective analysis of national surveillance data from all 37 States in Nigeria between February 27, 2020, and April 3, 2021. The outcome variable was mortality amongst persons who tested positive for SARS-CoV-2 by Reverse-Transcriptase Poly…

  • Analysis of sociodemographic and clinical factors associated with Lassa fever disease and mortality in Nigeria

    Open AccessAdebola Olayinka, Kelly Elimian et al.ARTICLEPLOS Global Public Health2022

    Over past decades, there has been increasing geographical spread of Lassa fever (LF) cases across Nigeria and other countries in West Africa. This increase has been associated with significant morbidity and mortality despite increasing focus on the disease by both local and international scientists. Many of these studies on LF have been limited to few specialised centres in the country. This study was done to identify sociodemographic and clinica…

  • Epidemiological description of and response to a large yellow fever outbreak in Edo state Nigeria, September 2018 - January 2019

    Open AccessE Nwachukwu William, John Oladejo et al.ARTICLEBMC Public Health2022

    Edo State is one of the states in Nigeria with the highest burden of yellow fever. More males were affected among the confirmed. Major symptoms include fever, jaundice, weakness, and bleeding. Majority of surveillance performance indicators were above target. There is a high risk of transmission of the disease in the state. Low yellow fever vaccination coverage, and presence of yellow fever vectors (Ae.aegypti, Ae.albopictus and Ae.simpsoni) are …

  • Epidemiological comparison of the first and second waves of the Covid-19 pandemic in Nigeria, February 2020–April 2021

    Open AccessOluwatosin Akande, Kelly Elimian et al.ARTICLEBMJ Global Health2021

    BACKGROUND: With reports of surges in COVID-19 case numbers across over 50 countries, country-level epidemiological analysis is required to inform context-appropriate response strategies for containment and mitigation of the outbreak. We aimed to compare the epidemiological features of the first and second waves of COVID-19 in Nigeria. METHODS: We conducted a retrospective analysis of the Surveillance Outbreak Response Management and Analysis Sys…

  • Electronic reporting of integrated disease surveillance and response

    Open AccessLuka Mangveep Ibrahim, Ifeanyi Okudo et al.ARTICLEBMC Public Health2021

    The eIDSR has increased the number of health facilities reporting IDSR, enabled early identification, reporting, and verification of alerts, improved timeliness and completeness of reports, and supportive supervision of staff at the operational levels. It was well accepted by the stakeholder as a system that made reporting easy with the potential to improve the public health surveillance system in Nigeria

  • Determination of the emergency phase for response against endemic disease outbreak

    Open AccessOladipupo Ipadeola, Yuki Furuse et al.ARTICLEJournal of Global Health2020

  • Nigeria’s public health response to the Covid-19 pandemic

    Open AccessChioma Dan-Nwafor, Chinwe Lucia Ochu et al.ARTICLEJournal of Global Health2020

    The novel coronavirus disease 2019, COVID-19, which is caused by severe acute respiratory syndrome \nvirus 2 (SARS-CoV-2) [1] was first reported in December 2019 by Chinese Health Authorities following an outbreak of pneumonia of unknown origin in Wuhan, Hubei Province [2,3]. SARS-CoV-2 is \nlikely of zoonotic origin, similar to SARS and Middle East Respiratory Syndrome (MERS), and transmitted between humans through respiratory droplets and fomit…